Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-22-016819
Filing Date
2022-12-21
Accepted
2022-12-21 17:16:51
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM S-3 mnpr_s3.htm S-3 327309
2 EX-5.1 mnpr_ex51.htm EX-5.1 9762
3 EX-5.2 mnpr_ex52.htm EX-5.2 10733
4 EX-23.1 mnpr_ex231.htm EX-23.1 1845
5 FEE TABLE mnpr_ex107.htm EX-FILING FEES 35249
6 mnpr_s3img29.jpg GRAPHIC 4841
7 mnpr_s3img28.jpg GRAPHIC 2516
8 mnpr_s3img26.jpg GRAPHIC 2516
9 mnpr_s3img25.jpg GRAPHIC 4841
10 mnpr_s3img24.jpg GRAPHIC 8253
11 mnpr_s3img23.jpg GRAPHIC 6132
12 mnpr_ex52img7.jpg GRAPHIC 7040
13 mnpr_ex52img6.jpg GRAPHIC 5596
14 mnpr_ex52img5.jpg GRAPHIC 3260
15 mnpr_ex51img2.jpg GRAPHIC 7256
  Complete submission text file 0001654954-22-016819.txt   459065
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268935 | Film No.: 221479125
SIC: 2834 Pharmaceutical Preparations